Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Sep '25 Sep 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	4,154	4,352	3,166	1,909	1,532	967	Upgrade
Market Cap Growth	-19.92%	37.47%	65.87%	24.59%	58.47%	13.17%	Upgrade
Enterprise Value	3,460	3,689	2,632	1,536	1,220	735	Upgrade
PE Ratio	33.25	50.54	320.10	-	-	-	Upgrade
PS Ratio	13.58	15.51	69.02	-	-	-	Upgrade
PB Ratio	4.69	4.76	4.49	3.91	2.94	4.05	Upgrade
P/TBV Ratio	4.69	4.76	4.49	3.91	2.94	4.05	Upgrade
P/FCF Ratio	26.31	37.81	-	-	-	-	Upgrade
P/OCF Ratio	24.97	36.51	-	-	-	-	Upgrade
EV/Sales Ratio	11.26	13.15	57.38	-	-	-	Upgrade
EV/EBITDA Ratio	26.18	36.14	-	-	-	-	Upgrade
EV/EBIT Ratio	26.66	37.01	-	-	-	-	Upgrade
EV/FCF Ratio	21.91	32.04	-	-	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01	Upgrade
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-	Upgrade
Debt / FCF Ratio	0.05	0.06	-	-	-	-	Upgrade
Asset Turnover	0.35	0.31	0.07	-	-	-	Upgrade
Inventory Turnover	1.10	1.20	-	-	-	-	Upgrade
Quick Ratio	9.13	6.89	17.35	13.14	17.02	17.56	Upgrade
Current Ratio	9.68	7.28	17.77	13.30	17.18	17.80	Upgrade
Return on Equity (ROE)	15.61%	10.34%	1.68%	-25.09%	-15.71%	-13.00%	Upgrade
Return on Assets (ROA)	9.23%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%	Upgrade
Return on Capital (ROIC)	10.00%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%	Upgrade
Return on Capital Employed (ROCE)	14.40%	10.80%	-	-	-	-	Upgrade
Earnings Yield	3.01%	1.98%	0.31%	-6.86%	-3.99%	-2.72%	Upgrade
FCF Yield	3.80%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%	Upgrade
Buyback Yield / Dilution	-1.66%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.